Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

AxyS initiates phase Ib studies of APC-2059 in psoriasis

Feb. 16, 1999

Human Genome Sciences initiates phase II clinical trials of new wound-healing agent

Feb. 15, 1999

Pierre Fabre Dermatologie to commercialize Allergan's Zorac in Europe

Feb. 12, 1999

ADCON-L improves clinical outcome following lumbar discectomy

Feb. 11, 1999

Micrologix Biotech continues preclinical testing on acne drugs

Feb. 8, 1999

Schering discloses new leukotriene antagonists particularly useful as dermatological products

Feb. 3, 1999

Gliatech initiates ADCON-P pivotal clinical trial

Jan. 29, 1999

Vertex initiates phase II psoriasis trial of VX-497

Jan. 22, 1999

Adolor receives additional patent protection for ADL-2-1294

Jan. 21, 1999

ProCyte and Merck enter distribution agreement

Jan. 20, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Anticancer drug exerts potent HIV antiviral effects
BioWorld Science
A new isoform of proliferating cell nuclear antigen (PCNA) – cancer-associated PCNA (caPCNA) – that is specifically expressed in cancer tissues has been reported....